NASDAQ: NRBONeurobo Pharmaceuticals Inc Stock Ownership - Who owns Neurobo Pharmaceuticals?
Insider buying vs selling
Have Neurobo Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when NRBO insiders and whales buy or sell their stock.
NRBO Shareholders
What type of owners hold Neurobo Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Na Yeon Kim | 125.94% | 6,178,535 | $21.38M | Insider |
| Einvestment Inc | 122.64% | 6,016,669 | $20.82M | Insider |
| Donga St Co Ltd | 58.72% | 2,880,612 | $9.97M | Insider |
| Jeong Gyun Oh | 41.95% | 2,057,893 | $7.12M | Insider |
| Charles Phd Bisgaier | 29.56% | 1,450,362 | $5.02M | Insider |
| Steven R. Phd Gullans | 25.08% | 1,230,252 | $4.26M | Insider |
| Goldman Sachs Group Inc | 24.88% | 1,220,502 | $4.22M | Insider |
| Akash Bakshi | 18.61% | 913,085 | $3.16M | Insider |
| David Lowenschuss | 16.43% | 806,247 | $2.79M | Insider |
| Jk Biopharma Solutions Inc | 16.31% | 800,170 | $2.77M | Insider |
NRBO vs Biotech Stocks
Neurobo Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.